These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 22415473)

  • 1. HIV-1 prevention for HIV-1 serodiscordant couples.
    Curran K; Baeten JM; Coates TJ; Kurth A; Mugo NR; Celum C
    Curr HIV/AIDS Rep; 2012 Jun; 9(2):160-70. PubMed ID: 22415473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experiences Using Pre-Exposure Prophylaxis for Safer Conception Among HIV Serodiscordant Heterosexual Couples in the United States.
    Bazzi AR; Leech AA; Biancarelli DL; Sullivan M; Drainoni ML
    AIDS Patient Care STDS; 2017 Aug; 31(8):348-355. PubMed ID: 28719229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study.
    Hallett TB; Baeten JM; Heffron R; Barnabas R; de Bruyn G; Cremin Í; Delany S; Garnett GP; Gray G; Johnson L; McIntyre J; Rees H; Celum C
    PLoS Med; 2011 Nov; 8(11):e1001123. PubMed ID: 22110407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fertility Intentions, Pregnancy, and Use of PrEP and ART for Safer Conception Among East African HIV Serodiscordant Couples.
    Heffron R; Thomson K; Celum C; Haberer J; Ngure K; Mugo N; Bukusi E; Katabira E; Odoyo J; Bulya N; Asiimwe S; Tindimwebwa E; Baeten JM;
    AIDS Behav; 2018 Jun; 22(6):1758-1765. PubMed ID: 28894986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of HIV-1 serodiscordant couples enrolled in a clinical trial of antiretroviral pre-exposure prophylaxis for HIV-1 prevention.
    Mujugira A; Baeten JM; Donnell D; Ndase P; Mugo NR; Barnes L; Campbell JD; Wangisi J; Tappero JW; Bukusi E; Cohen CR; Katabira E; Ronald A; Tumwesigye E; Were E; Fife KH; Kiarie J; Farquhar C; John-Stewart G; Kidoguchi L; Panteleeff D; Krows M; Shah H; Revall J; Morrison S; Ondrejcek L; Ingram C; Coombs RW; Lingappa JR; Celum C;
    PLoS One; 2011; 6(10):e25828. PubMed ID: 21998703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. I Knew I Would Be Safer. Experiences of Kenyan HIV Serodiscordant Couples Soon After Pre-Exposure Prophylaxis (PrEP) Initiation.
    Ngure K; Heffron R; Curran K; Vusha S; Ngutu M; Mugo N; Celum C; Baeten JM
    AIDS Patient Care STDS; 2016 Feb; 30(2):78-83. PubMed ID: 26836236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PrEP Discontinuation and Prevention-Effective Adherence: Experiences of PrEP Users in Ugandan HIV Serodiscordant Couples.
    Gilbert HN; Wyatt MA; Pisarski EE; Muwonge TR; Heffron R; Katabira ET; Celum CL; Baeten JM; Haberer JE; Ware NC
    J Acquir Immune Defic Syndr; 2019 Nov; 82(3):265-274. PubMed ID: 31609925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Systematic Review of the Current Status of Safer Conception Strategies for HIV Affected Heterosexual Couples in Sub-Saharan Africa.
    Joseph Davey D; West S; Umutoni V; Taleghani S; Klausner H; Farley E; Shah R; Madni S; Orewa S; Kottamasu V; Rice V; Robbin Z; Wall KM
    AIDS Behav; 2018 Sep; 22(9):2916-2946. PubMed ID: 29869184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maximizing the impact of HIV prevention efforts: interventions for couples.
    Medley A; Baggaley R; Bachanas P; Cohen M; Shaffer N; Lo YR
    AIDS Care; 2013; 25(12):1569-80. PubMed ID: 23656251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a risk scoring tool to identify higher-risk HIV-1 serodiscordant couples for an antiretroviral-based HIV-1 prevention intervention.
    Irungu EM; Heffron R; Mugo N; Ngure K; Katabira E; Bulya N; Bukusi E; Odoyo J; Asiimwe S; Tindimwebwa E; Celum C; Baeten JM;
    BMC Infect Dis; 2016 Oct; 16(1):571. PubMed ID: 27751179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Counseling Framework for HIV-Serodiscordant Couples on the Integrated Use of Antiretroviral Therapy and Pre-exposure Prophylaxis for HIV Prevention.
    Morton JF; Celum C; Njoroge J; Nakyanzi A; Wakhungu I; Tindimwebwa E; Ongachi S; Sedah E; Okwero E; Ngure K; Odoyo J; Bulya N; Haberer JE; Baeten JM; Heffron R;
    J Acquir Immune Defic Syndr; 2017 Jan; 74 Suppl 1(Suppl 1):S15-S22. PubMed ID: 27930607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiretroviral Therapy to Prevent HIV Acquisition in Serodiscordant Couples in a Hyperendemic Community in Rural South Africa.
    Oldenburg CE; Bärnighausen T; Tanser F; Iwuji CC; De Gruttola V; Seage GR; Mimiaga MJ; Mayer KH; Pillay D; Harling G
    Clin Infect Dis; 2016 Aug; 63(4):548-54. PubMed ID: 27208044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional analysis of
    Bochner AF; Baeten JM; Rustagi AS; Nakku-Joloba E; Lingappa JR; Mugo NR; Bukusi EA; Kapiga S; Delany-Moretlwe S; Celum C; Barnabas RV;
    Sex Transm Infect; 2017 Nov; 93(7):520-529. PubMed ID: 28377421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Healthcare providers' understanding of HIV serodiscordance in South Africa and Uganda: implications for HIV prevention in sub-Saharan Africa.
    Greener R; Milford C; Bajunirwe F; Mosery FN; Ng CK; Rifkin R; Kastner J; Pillay L; Kaida A; Bangsberg DR; Smit JA; Matthews LT
    Afr J AIDS Res; 2018 Jul; 17(2):137-144. PubMed ID: 29745290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No Evidence of Sexual Risk Compensation Following PrEP Initiation Among Heterosexual HIV Serodiscordant Couples in Kenya and Uganda.
    Ortblad KF; Stalter RM; Bukusi EA; Ngure K; Mujugura A; Celum C; Baeten JM; Heffron R
    AIDS Behav; 2020 May; 24(5):1365-1375. PubMed ID: 31696370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modelling the impact and cost-effectiveness of combination prevention amongst HIV serodiscordant couples in Nigeria.
    Mitchell KM; Lépine A; Terris-Prestholt F; Torpey K; Khamofu H; Folayan MO; Musa J; Anenih J; Sagay AS; Alhassan E; Idoko J; Vickerman P
    AIDS; 2015 Sep; 29(15):2035-44. PubMed ID: 26355574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sexual and reproductive health in HIV serodiscordant couples.
    Makwe CC; Giwa-Osagie OF
    Afr J Reprod Health; 2013 Dec; 17(4 Spec No):99-106. PubMed ID: 24689321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Willingness of Kenyan HIV-1 serodiscordant couples to use antiretroviral-based HIV-1 prevention strategies.
    Heffron R; Ngure K; Mugo N; Celum C; Kurth A; Curran K; Baeten JM
    J Acquir Immune Defic Syndr; 2012 Sep; 61(1):116-9. PubMed ID: 22595872
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral pre-exposure prophylaxis (PrEP) for prevention of HIV in serodiscordant heterosexual couples in the United States: opportunities and challenges.
    McMahon JM; Myers JE; Kurth AE; Cohen SE; Mannheimer SB; Simmons J; Pouget ER; Trabold N; Haberer JE
    AIDS Patient Care STDS; 2014 Sep; 28(9):462-74. PubMed ID: 25045996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maintenance of safe sex behavior by HIV-serodiscordant heterosexual couples.
    Skurnick JH; Abrams J; Kennedy CA; Valentine SN; Cordell JR
    AIDS Educ Prev; 1998 Dec; 10(6):493-505. PubMed ID: 9883285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.